Indication

Asthma with Allergic Rhinitis

1 clinical trial

1 product

Clinical trial

Tezepelumab in the Treatment of Co-morbid Allergic Rhinitis and Allergic Asthma Study (TEZARS) - An Open-Label Exploratory Mechanistic Pilot Study to Evaluate Tezepelumab Efficacy in Asthma and Allergic Rhinitis

Status: Recruiting, Estimated PCD: 2026-04-30

Product